Dyspnoea and diffuse pulmonary nodules in a patient with pulmonary veno-occlusive disease: a case report and literature review. [PDF]
He Y, Xie M, Liu X, Liu X.
europepmc +1 more source
Inhalation of hydrogen gas protects against mitomycin-induced pulmonary veno-occlusive disease. [PDF]
Zhang C +8 more
europepmc +1 more source
Reversal of pulmonary veno-occlusive disease phenotypes by inhibition of the integrated stress response. [PDF]
Prabhakar A +13 more
europepmc +1 more source
Anesthesia for pulmonary veno-occlusive disease: the dilemma and what we should know as anesthesiologists: A case report. [PDF]
Foong TW +3 more
europepmc +1 more source
Pulmonary capillary hemangiomatosis/veno-occlusive disease diagnosed by transbronchial cryobiopsy
Venerino Poletti +5 more
doaj +1 more source
Cobalamin C deficiency: a rare but treatable genetic cause of pulmonary hypertension
Julien Grynblat +2 more
doaj +1 more source
ERG-APLNR Axis Controls Pulmonary Venule Endothelial Proliferation in Pulmonary Veno-Occlusive Disease [PDF]
BackgroundPulmonary veno-occlusive disease is caused by excessive cell proliferation and fibrosis, which obliterate the lumen of pulmonary venules, leading to pulmonary hypertension, right ventricular failure, and death.
Grace A Lin +2 more
exaly +2 more sources
Pulmonary Veno-Occlusive Disease
Pulmonary veno-occlusive disease (PVOD) is a rare form of pulmonary hypertension (PH) characterised by preferential remodelling of the pulmonary venules. In the current PH classification, PVOD and pulmonary capillary haemangiomatosis (PCH) are considered
S French, S Jennings, S L Priestnall
exaly +2 more sources

